GAAP Financial Statements
VACCINEX, INC. (VCNX)
0 quarters · 1 annual periods · CIK 0001205922
Annual (1)
| Period | Form | Revenue | Gross Profit | Op. Income | Net Income | EPS (Basic) | EPS (Dil.) | Assets | Cash |
|---|---|---|---|---|---|---|---|---|---|
| FY FY2024 | 10-K | $601.0K | — | -$18.7M | -$18.6M | $-8.88 | $-8.88 | $2.6M | $1.1M |
Source: SEC EDGAR XBRL filings. Per-period figures are pulled from the original 10-Q / 10-K / 20-F submissions. Balance-sheet items (Assets, Cash, Equity) are point-in-time at period end.